1
|
Swanton C, Bernard E, Abbosh C, André F, Auwerx J, Balmain A, Bar-Sagi D, Bernards R, Bullman S, DeGregori J, Elliott C, Erez A, Evan G, Febbraio MA, Hidalgo A, Jamal-Hanjani M, Joyce JA, Kaiser M, Lamia K, Locasale JW, Loi S, Malanchi I, Merad M, Musgrave K, Patel KJ, Quezada S, Wargo JA, Weeraratna A, White E, Winkler F, Wood JN, Vousden KH, Hanahan D. Embracing cancer complexity: Hallmarks of systemic disease. Cell 2024; 187:1589-1616. [PMID: 38552609 DOI: 10.1016/j.cell.2024.02.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2023] [Revised: 01/25/2024] [Accepted: 02/08/2024] [Indexed: 04/02/2024]
Abstract
The last 50 years have witnessed extraordinary developments in understanding mechanisms of carcinogenesis, synthesized as the hallmarks of cancer. Despite this logical framework, our understanding of the molecular basis of systemic manifestations and the underlying causes of cancer-related death remains incomplete. Looking forward, elucidating how tumors interact with distant organs and how multifaceted environmental and physiological parameters impinge on tumors and their hosts will be crucial for advances in preventing and more effectively treating human cancers. In this perspective, we discuss complexities of cancer as a systemic disease, including tumor initiation and promotion, tumor micro- and immune macro-environments, aging, metabolism and obesity, cancer cachexia, circadian rhythms, nervous system interactions, tumor-related thrombosis, and the microbiome. Model systems incorporating human genetic variation will be essential to decipher the mechanistic basis of these phenomena and unravel gene-environment interactions, providing a modern synthesis of molecular oncology that is primed to prevent cancers and improve patient quality of life and cancer outcomes.
Collapse
Affiliation(s)
- Charles Swanton
- The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
| | - Elsa Bernard
- The Francis Crick Institute, London, UK; INSERM U981, Gustave Roussy, Villejuif, France
| | | | - Fabrice André
- INSERM U981, Gustave Roussy, Villejuif, France; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Paris Saclay University, Kremlin-Bicetre, France
| | - Johan Auwerx
- Laboratory of Integrative Systems Physiology, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland
| | - Allan Balmain
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
| | | | - René Bernards
- Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands
| | - Susan Bullman
- Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - James DeGregori
- Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
| | | | - Ayelet Erez
- Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
| | - Gerard Evan
- The Francis Crick Institute, London, UK; Kings College London, London, UK
| | - Mark A Febbraio
- Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia
| | - Andrés Hidalgo
- Department of Immunobiology, Yale University, New Haven, CT 06519, USA; Area of Cardiovascular Regeneration, Centro Nacional de Investigaciones Cardiovasculares, 28029 Madrid, Spain
| | - Mariam Jamal-Hanjani
- Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
| | - Johanna A Joyce
- Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland
| | | | - Katja Lamia
- Department of Molecular Medicine, Scripps Research Institute, La Jolla, CA, USA
| | - Jason W Locasale
- Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA; Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC, USA
| | - Sherene Loi
- Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; The Sir Department of Medical Oncology, The University of Melbourne, Parkville, VIC, Australia
| | | | - Miriam Merad
- Department of immunology and immunotherapy, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Kathryn Musgrave
- Translational and Clinical Research Institute, Newcastle University, Newcastle, UK; Department of Haematology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
| | - Ketan J Patel
- MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK
| | - Sergio Quezada
- Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK
| | - Jennifer A Wargo
- Department of Surgical Oncology, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Ashani Weeraratna
- Sidney Kimmel Cancer Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Eileen White
- Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA; Ludwig Princeton Branch, Ludwig Institute for Cancer Research, Princeton, NJ, USA
| | - Frank Winkler
- Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuro-oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - John N Wood
- Molecular Nociception Group, WIBR, University College London, London, UK
| | | | - Douglas Hanahan
- Lausanne Branch, Ludwig Institute for Cancer Research, Lausanne, Switzerland; Swiss institute for Experimental Cancer Research (ISREC), EPFL, Lausanne, Switzerland; Agora Translational Cancer Research Center, Lausanne, Switzerland.
| |
Collapse
|
2
|
Giles HV, Drayson MT, Kishore B, Pawlyn C, Kaiser M, Cook G, de Tute R, Owen RG, Cairns D, Menzies T, Davies FE, Morgan GJ, Pratt G, Jackson GH. Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry. Blood Cancer J 2024; 14:50. [PMID: 38499538 PMCID: PMC10948753 DOI: 10.1038/s41408-024-00995-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2023] [Revised: 01/17/2024] [Accepted: 01/22/2024] [Indexed: 03/20/2024] Open
Abstract
Deeper responses are associated with improved survival in patients being treated for myeloma. However, the sensitivity of the current blood-based assays is limited. Historical studies suggested that normalisation of the serum free light chain (FLC) ratio in patients who were negative by immunofixation electrophoresis (IFE) was associated with improved outcomes. However, recently this has been called into question. Mass spectrometry (MS)-based FLC assessments may offer a superior methodology for the detection of monoclonal FLC due to greater sensitivity. To test this hypothesis, all available samples from patients who were IFE negative after treatment with carfilzomib and lenalidomide-based induction and autologous stem cell transplantation (ASCT) in the Myeloma XI trial underwent FLC-MS testing. FLC-MS response assessments from post-induction, day+100 post-ASCT and six months post-maintenance randomisation were compared to serum FLC assay results. Almost 40% of patients had discordant results and 28.7% of patients with a normal FLC ratio had residual monoclonal FLC detectable by FLC-MS. FLC-MS positivity was associated with reduced progression-free survival (PFS) but an abnormal FLC ratio was not. This study demonstrates that FLC-MS provides a superior methodology for the detection of residual monoclonal FLC with FLC-MS positivity identifying IFE-negative patients who are at higher risk of early progression.
Collapse
Affiliation(s)
- H V Giles
- University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
- University of Birmingham, Birmingham, UK.
| | | | - B Kishore
- University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| | - C Pawlyn
- The Institute of Cancer Research, London and The Royal Marsden Hospital, London, UK
| | - M Kaiser
- The Institute of Cancer Research, London and The Royal Marsden Hospital, London, UK
| | - G Cook
- Leeds Cancer Research UK Institute of Clinical Trials Research, University of Leeds, Leeds, UK
| | - R de Tute
- Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals Trust, Leeds, UK
| | - R G Owen
- Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals Trust, Leeds, UK
| | - D Cairns
- Leeds Cancer Research UK Institute of Clinical Trials Research, University of Leeds, Leeds, UK
| | - T Menzies
- Leeds Cancer Research UK Institute of Clinical Trials Research, University of Leeds, Leeds, UK
| | - F E Davies
- Myeloma Research Program, Perlmutter Cancer, NYU Langone Health, New York, USA
| | - G J Morgan
- Myeloma Research Program, Perlmutter Cancer, NYU Langone Health, New York, USA
| | - G Pratt
- University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
- University of Birmingham, Birmingham, UK
| | - G H Jackson
- Department of Haematology, University of Newcastle, Newcastle upon Tyne, UK
| |
Collapse
|
3
|
Zaaimi B, Turnbull M, Hazra A, Wang Y, Gandara C, McLeod F, McDermott EE, Escobedo-Cousin E, Idil AS, Bailey RG, Tardio S, Patel A, Ponon N, Gausden J, Walsh D, Hutchings F, Kaiser M, Cunningham MO, Clowry GJ, LeBeau FEN, Constandinou TG, Baker SN, Donaldson N, Degenaar P, O'Neill A, Trevelyan AJ, Jackson A. Closed-loop optogenetic control of the dynamics of neural activity in non-human primates. Nat Biomed Eng 2023; 7:559-575. [PMID: 36266536 PMCID: PMC7614485 DOI: 10.1038/s41551-022-00945-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2020] [Accepted: 08/14/2022] [Indexed: 11/08/2022]
Abstract
Electrical neurostimulation is effective in the treatment of neurological disorders, but associated recording artefacts generally limit its applications to open-loop stimuli. Real-time and continuous closed-loop control of brain activity can, however, be achieved by pairing concurrent electrical recordings and optogenetics. Here we show that closed-loop optogenetic stimulation with excitatory opsins enables the precise manipulation of neural dynamics in brain slices from transgenic mice and in anaesthetized non-human primates. The approach generates oscillations in quiescent tissue, enhances or suppresses endogenous patterns in active tissue and modulates seizure-like bursts elicited by the convulsant 4-aminopyridine. A nonlinear model of the phase-dependent effects of optical stimulation reproduced the modulation of cycles of local-field potentials associated with seizure oscillations, as evidenced by the systematic changes in the variability and entropy of the phase-space trajectories of seizures, which correlated with changes in their duration and intensity. We also show that closed-loop optogenetic neurostimulation could be delivered using intracortical optrodes incorporating light-emitting diodes. Closed-loop optogenetic approaches may be translatable to therapeutic applications in humans.
Collapse
Affiliation(s)
- B Zaaimi
- Biosciences Institute, Newcastle University, Newcastle, UK
- School of Life and Health Sciences, Aston University, Birmingham, UK
| | - M Turnbull
- Biosciences Institute, Newcastle University, Newcastle, UK
| | - A Hazra
- Biosciences Institute, Newcastle University, Newcastle, UK
| | - Y Wang
- School of Computing, Newcastle University, Newcastle, UK
| | - C Gandara
- Biosciences Institute, Newcastle University, Newcastle, UK
| | - F McLeod
- Biosciences Institute, Newcastle University, Newcastle, UK
| | - E E McDermott
- Biosciences Institute, Newcastle University, Newcastle, UK
| | | | - A Shah Idil
- Department of Medical Physics and Biomedical Engineering, University College London, London, UK
| | - R G Bailey
- School of Engineering, Newcastle University, Newcastle, UK
| | - S Tardio
- School of Engineering, Newcastle University, Newcastle, UK
| | - A Patel
- School of Engineering, Newcastle University, Newcastle, UK
| | - N Ponon
- School of Engineering, Newcastle University, Newcastle, UK
| | - J Gausden
- School of Engineering, Newcastle University, Newcastle, UK
| | - D Walsh
- Biosciences Institute, Newcastle University, Newcastle, UK
| | - F Hutchings
- School of Computing, Newcastle University, Newcastle, UK
| | - M Kaiser
- School of Computing, Newcastle University, Newcastle, UK
- NIHR, Nottingham Biomedical Research Centre, School of Medicine, University of Nottingham, Nottingham, UK
- Sir Peter Mansfield Imaging Centre, School of Medicine, University of Nottingham, Nottingham, UK
- Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - M O Cunningham
- School of Medicine, Trinity College Dublin, Dublin, Ireland
| | - G J Clowry
- Biosciences Institute, Newcastle University, Newcastle, UK
| | - F E N LeBeau
- Biosciences Institute, Newcastle University, Newcastle, UK
| | - T G Constandinou
- Department of Electrical and Electronic Engineering, Imperial College, London, UK
| | - S N Baker
- Biosciences Institute, Newcastle University, Newcastle, UK
| | - N Donaldson
- Department of Medical Physics and Biomedical Engineering, University College London, London, UK
| | - P Degenaar
- School of Engineering, Newcastle University, Newcastle, UK
| | - A O'Neill
- School of Engineering, Newcastle University, Newcastle, UK
| | - A J Trevelyan
- Biosciences Institute, Newcastle University, Newcastle, UK
| | - A Jackson
- Biosciences Institute, Newcastle University, Newcastle, UK.
| |
Collapse
|
4
|
Kretschmann J, Früchtl L, Fischer ML, Kaiser M, Müller H, Spilke J, Mielenz N, Möbius G, Bittner-Schwerda L, Steinhöfel I, Baumgartner W, Starke A. [Effect of a multimodal pain management protocol and age on wound healing after thermal disbudding of female German Holstein calves]. SCHWEIZ ARCH TIERH 2021; 163:836-850. [PMID: 34881716 DOI: 10.17236/sat00330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
INTRODUCTION Hot-iron disbudding of calves is a stressful and painful procedure and leaves a burn wound. Pain management procedures and the effects of hot-iron disbudding on biochemical markers of pain perception and stress response have been widely investigated in recent years. The aim of this study was to investigate the potential effects of pain management and age of the calf on the healing of burn wounds caused by disbudding. 327 healthy female German Holstein calves were included in this randomised, triple-blinded, prospective study. Calves were either disbudded at the age of four to 10 or 15 to 28 days using a gas-powered hot iron. Each calf was randomly allocated to one of nine possible treatment groups (BG). All calves received either the active ingredients to be tested (xylazine hydrochloride with 0.2 or 0.05 mg / kg body mass (BM) intramuscular for sedation, procaine hydrochloride (2 %) each 8 ml locally on both sides subcutaneously (SC) to the cornual nerves, meloxicam with 0,5 mg / kg BM SC for anti-inflammatory purposes) or an identical amount of saline solution (placebo). Calves in the group `thermE` and `ScheinE` received only placebo. In group `ScheinE` disbudding was simulated and in `thermE` it was carried out. The calves were clinically monitored starting one day before and ending 28 days after the procedure and the burn wounds were assessed. Both the rectal temperature and parameters of wound healing changed significantly during the study period and had characteristic profiles over time. Wound healing was not influenced by the different analgesic protocols, indicating that a multimodal analgesia does not pose a risk for wound healing after thermal disbudding. There were no observed differences between the age groups. The results of this study show, that disbudding of young calves and a multimodal pain management protocol does not affect wound healing in calves.
Collapse
Affiliation(s)
- J Kretschmann
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - L Früchtl
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - M-L Fischer
- Institut für Tierhygiene und Öffentliches Veterinärwesen der Veterinärmedizinischen Fakultät der Universität Leipzig, Deutschland
| | - M Kaiser
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - H Müller
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - J Spilke
- Institut für -Agrar- und Ernährungswissenschaften, Arbeitsgruppe Biometrie und Agrarinformatik, Martin-Luther-Universität, Halle-Wittenberg, 06120 Halle (Saale), Deutschland
| | - N Mielenz
- Institut für -Agrar- und Ernährungswissenschaften, Arbeitsgruppe Biometrie und Agrarinformatik, Martin-Luther-Universität, Halle-Wittenberg, 06120 Halle (Saale), Deutschland
| | - G Möbius
- Institut für Tierhygiene und Öffentliches Veterinärwesen der Veterinärmedizinischen Fakultät der Universität Leipzig, Deutschland
| | - L Bittner-Schwerda
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - I Steinhöfel
- Landesamt für Umwelt, Landwirtschaft und Geologie, Abteilung Landwirtschaft, Köllitsch
| | - W Baumgartner
- Universitätsklinik für Wiederkäuer, Veterinärmedizinische Universität Wien, Wien, Österreich
| | - A Starke
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| |
Collapse
|
5
|
Wagner R, Fieseler H, Kaiser M, Müller H, Mielenz N, Spilke J, Gottschalk J, Einspanier A, Palme R, Rizk A, Möbius G, Baumgartner W, Rachidi F, Starke A. [Cortisol concentrations in sheep before, during and after sham foot trimming on a tilt table - the suitability of different matrices]. SCHWEIZ ARCH TIERH 2021; 164:753-766. [PMID: 34758951 DOI: 10.17236/sat00325] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
INTRODUCTION Matrices that can be collected non-invasively for quantification of a stress response in sheep have received little attention in the veterinary literature. This study examines the suitability of blood, tears and saliva for determining a stress response in sheep undergoing sham foot trimming on a tilt table. The cortisol concentration of blood, tears and saliva and the concentration of cortisol metabolites in faeces were measured in 13 healthy Meat Merino ewes once a day for six days. Sham foot trimming on a tilt table was used as the stressor and was done during a one-hour period on day 4; cortisol concentrations of blood and tears were measured at 0, 10, 20, 30, 40 and 60 minutes. Cortisol concentrations of blood (maximum at 30 minutes) and tears (maximum at 40 minutes) increased during the procedure and then decreased. There were significant correlations between cortisol concentrations of blood and tears (p = 0,04) during sham foot trimming (area under the curve, 0 to 60 minutes). Over the entire 6-day study period, significant correlations were seen between the cortisol concentrations of blood and tears (r = 0,55; p.
Collapse
Affiliation(s)
- R Wagner
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - H Fieseler
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - M Kaiser
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - H Müller
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - N Mielenz
- Institut für -Agrar- und Ernährungswissenschaften, Arbeitsgruppe Biometrie und Agrarinformatik, Martin-Luther-Universität, Halle-Wittenberg, 06120 Halle (Saale), Deutschland
| | - J Spilke
- Institut für -Agrar- und Ernährungswissenschaften, Arbeitsgruppe Biometrie und Agrarinformatik, Martin-Luther-Universität, Halle-Wittenberg, 06120 Halle (Saale), Deutschland
| | - J Gottschalk
- Veterinär-Physiologisch-Chemisches Institut, Biochemie der Veterinär-medizinischen Fakultät, Universität Leipzig, Deutschland
| | - A Einspanier
- Veterinär-Physiologisch-Chemisches Institut, Biochemie der Veterinär-medizinischen Fakultät, Universität Leipzig, Deutschland
| | - R Palme
- Abteilung für Physiologie, Pathophysiologie und -experimentelle Endokrinologie, Veterinärmedizinische Universität Wien, Österreich
| | - A Rizk
- Abteilung Chirurgie, -Anästhesiologie und Radiologie, Veterinärmedizinische Fakultät, Universität Mansoura, Ägypten
| | - G Möbius
- Institut für Tierhygiene und Öffentliches Veterinärwesen der Veterinärmedizinischen Fakultät der Universität Leipzig, Deutschland
| | - W Baumgartner
- Universitätsklinik für Wiederkäuer, Veterinärmedizinische Universität Wien, Wien, Österreich
| | - F Rachidi
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| | - A Starke
- Klinik für Klauentiere, Veterinärmedizinische Fakultät, Universität Leipzig, Deutschland
| |
Collapse
|
6
|
Hesse U, Hesse A, Hesse L, Schultz E, Kaiser M. Lipödem heute: Zwischen konservativer Therapie, Liposuktion und Adipositaschirurgie. Aktuelle Dermatologie 2021. [DOI: 10.1055/a-1525-5956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
ZusammenfassungDie zunehmende Prävalenz des Lipödems geht einher mit einer demografischen Zunahme der Adipositas per magna.Konservative und operative Maßnahmen ermöglichen eine ausgeprägte Befund- und Beschwerdebesserung.Die exakte Diagnose und Differenzierung zwischen therapiebedürftiger Adipositas und therapiebedürftigem Lipödem entscheiden über Erfolg und Misserfolg der eingeleiteten Therapie.Nach konservativem Therapieversuch kann die operative Versorgung bei Ausbleiben einer entsprechenden Besserung durch Liposuktion oder adipositaschirurgische Intervention bei einem erheblichen Teil der Betroffenen die konservative Therapie reduzieren bzw. teilweise sogar ganz überflüssig machen.
Collapse
Affiliation(s)
- U. Hesse
- Adipositas und Metabolische Chirurgie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität, Nürnberg
- Praxis für Chirurgie und Venentherapie, Sindelfingen
| | - A. Hesse
- Praxis für Allgemeinmedizin, Stuttgart
| | - L. Hesse
- Cand. Med. Universität Pécs, Ungarn
| | - E. Schultz
- Klinik für Dermatologie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität, Nürnberg
| | - M. Kaiser
- Klinik für Plastische, Wiederherstellende und Handchirurgie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität, Nürnberg
| |
Collapse
|
7
|
Meijer AJM, Diepstraten FA, Langer T, Broer L, Domingo IK, Clemens E, Uitterlinden AG, de Vries ACH, van Grotel M, Vermeij WP, Ozinga RA, Binder H, Byrne J, van Dulmen-den Broeder E, Garrè ML, Grabow D, Kaatsch P, Kaiser M, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, Kepakova K, Tissing WJE, van der Kooi ALF, Kremer LCM, Kruseova J, Pluijm SMF, Kuehni CE, van der Pal HJH, Parfitt R, Spix C, Tillmanns A, Deuster D, Matulat P, Calaminus G, Hoetink AE, Elsner S, Gebauer J, Haupt R, Lackner H, Blattmann C, Neggers SJCMM, Rassekh SR, Wright GEB, Brooks B, Nagtegaal AP, Drögemöller BI, Ross CJD, Bhavsar AP, Am Zehnhoff-Dinnesen AG, Carleton BC, Zolk O, van den Heuvel-Eibrink MM. TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ Precis Oncol 2021; 5:64. [PMID: 34262104 PMCID: PMC8280110 DOI: 10.1038/s41698-021-00178-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2020] [Accepted: 04/16/2021] [Indexed: 12/24/2022] Open
Abstract
In children with cancer, the heterogeneity in ototoxicity occurrence after similar treatment suggests a role for genetic susceptibility. Using a genome-wide association study (GWAS) approach, we identified a genetic variant in TCERG1L (rs893507) to be associated with hearing loss in 390 non-cranial irradiated, cisplatin-treated children with cancer. These results were replicated in two independent, similarly treated cohorts (n = 192 and 188, respectively) (combined cohort: P = 5.3 × 10-10, OR 3.11, 95% CI 2.2-4.5). Modulating TCERG1L expression in cultured human cells revealed significantly altered cellular responses to cisplatin-induced cytokine secretion and toxicity. These results contribute to insights into the genetic and pathophysiological basis of cisplatin-induced ototoxicity.
Collapse
Affiliation(s)
- A J M Meijer
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
| | - F A Diepstraten
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
| | - T Langer
- Department of Pediatric Oncology and Hematology, University Hospital for Children and Adolescents, Lübeck, Germany
| | - L Broer
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
| | - I K Domingo
- Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, Canada
| | - E Clemens
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands
| | - A G Uitterlinden
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
| | - A C H de Vries
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands
| | - M van Grotel
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
| | - W P Vermeij
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Oncode Institute, Utrecht, The Netherlands
| | - R A Ozinga
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Oncode Institute, Utrecht, The Netherlands
| | - H Binder
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
- Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
| | - J Byrne
- Boyne Research Institute, Drogheda, Ireland
| | - E van Dulmen-den Broeder
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- VU Medical Center, Amsterdam, The Netherlands
| | - M L Garrè
- Department of Neurooncology, IRCCS Istituto Giannina Gaslini, Genova, Italy
| | - D Grabow
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - P Kaatsch
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - M Kaiser
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - L Kenborg
- Childhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark
| | - J F Winther
- Childhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark
- Department of Clinical Medicine, Faculty of Health, Aarhus University and University Hospital, Aarhus, Denmark
| | - C Rechnitzer
- Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
| | - H Hasle
- Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
| | - T Kepak
- University Hospital Brno, Brno, Czech Republic
- International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic
| | - K Kepakova
- University Hospital Brno, Brno, Czech Republic
- International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic
| | - W J E Tissing
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - A L F van der Kooi
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Obstetrics and Gynecology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands
| | - L C M Kremer
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Oncology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands
| | - J Kruseova
- Department of Children Hemato-Oncology, Motol University Hospital Prague, Prague, Czech Republic
| | - S M F Pluijm
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
| | - C E Kuehni
- Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- Pediatric Hematology and Oncology, University Children's Hospital Bern, University of Bern, Bern, Switzerland
| | - H J H van der Pal
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Oncology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands
| | - R Parfitt
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
| | - C Spix
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - A Tillmanns
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
| | - D Deuster
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
| | - P Matulat
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
| | - G Calaminus
- Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany
| | - A E Hoetink
- Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Utrecht, Utrecht, The Netherlands
| | - S Elsner
- Institute of Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany
| | - J Gebauer
- Department of Internal Medicine, University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany
| | - R Haupt
- Epidemiology and Biostatistics Unit and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genova, Italy
| | - H Lackner
- Department of Pediatric and Adolescent Medicine, Medical University of Graz, Graz, Austria
| | - C Blattmann
- Department of Pediatric Oncology/Hematology/Immunology, Stuttgart Cancer Center, Olgahospital, Stuttgart, Germany
| | - S J C M M Neggers
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
| | - S R Rassekh
- BC Children's Hospital Research Institute, Vancouver, BC, Canada
- Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
| | - G E B Wright
- BC Children's Hospital Research Institute, Vancouver, BC, Canada
- Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
| | - B Brooks
- Audiology and Speech Pathology Department, BC Children's Hospital, Vancouver, BC, Canada
| | - A P Nagtegaal
- Departement of Otorhinolaryngology, Erasmus Medical Center, Rotterdam, The Netherlands
| | - B I Drögemöller
- BC Children's Hospital Research Institute, Vancouver, BC, Canada
- Faculty of Pharmaceutical Sciences, University of British Columbia, British Columbia, Canada
| | - C J D Ross
- BC Children's Hospital Research Institute, Vancouver, BC, Canada
- Faculty of Pharmaceutical Sciences, University of British Columbia, British Columbia, Canada
| | - A P Bhavsar
- Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, Canada
- Department of Medical Genetics, University of Alberta, Edmonton, AB, Canada
| | - A G Am Zehnhoff-Dinnesen
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
| | - B C Carleton
- BC Children's Hospital Research Institute, Vancouver, BC, Canada
- Faculty of Pharmaceutical Sciences, University of British Columbia, British Columbia, Canada
| | - O Zolk
- Institute of Clinical Pharmacology, Brandenburg Medical School, Rüdersdorf, Germany
| | - M M van den Heuvel-Eibrink
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands
| |
Collapse
|
8
|
van den Berg MH, van Dijk M, Byrne J, Berger C, Dirksen U, Winther JF, Fossa SD, Grabow D, Grandage VL, Haupt R, van den Heuvel-Eibrink MM, Kaiser M, Kepak T, van der Kooi ALF, Kremer LCM, Kruseova J, Lambalk CB, van Leeuwen FE, Leiper A, Modan-Moses D, Spix C, Twisk JWR, Ronckers CM, Kaatsch P, van Dulmen-den Broeder E. Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE). Hum Reprod 2021; 36:1561-1573. [PMID: 33744927 DOI: 10.1093/humrep/deab035] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2019] [Revised: 01/21/2021] [Indexed: 02/02/2023] Open
Abstract
STUDY QUESTION Which chemotherapeutic agents and body site-specific radiation fields are dose-dependently associated with an increased risk of fertility impairment in long-term female childhood, adolescent and young adulthood (CAYA) cancer survivors? SUMMARY ANSWER Busulfan, lower abdominal radiotherapy (RT) and total body irradiation (TBI) seem to be associated with fertility impairment at any dose, whereas gonadotoxicity of melphalan and procarbazine is suggested at medium/high (>140 mg/m2) or high dose (>5600 mg/m2) therapy, respectively. WHAT IS KNOWN ALREADY Several treatment-related fertility deficits, as assessed by both self-reported outcomes and hormonal markers are known to occur following treatment of CAYA cancer. However, knowledge regarding precise dose-related estimates of these treatment-related risks are scarce. STUDY DESIGN, SIZE, DURATION The current case-control study was nested within the PanCareLIFE cohort study. In total, 1332 CAYA survivors from 8 countries, 9 institutions and 11 cohorts, participated in and contributed data to the study. PARTICIPANTS/MATERIALS, SETTING, METHODS All participants were female 5-year CAYA cancer survivors. In total, 450 cases (fertility impaired survivors) and 882 matched controls (not fertility impaired survivors) were included. Fertility impairment was defined using both questionnaire data (primary or secondary amenorrhea; use of artificial reproductive techniques; unfulfilled wish to conceive) and hormonal data (FSH and anti-Müllerian hormone (AMH)). Multivariable logistic regression models were used to investigate the effect of (i) alkylating agent exposure, and (ii) dose categories for individual chemotherapeutic agents and for RT-exposed body sites. MAIN RESULTS AND THE ROLE OF CHANCE A positive dose-effect relationship between cyclophosphamide equivalent dose (CED) score and fertility impairment was found, with survivors with a CED score > 7121 mg/m2 being at a significantly increased risk of fertility impairment (odds ratio (95% CI) = 2.6 (1.9-3.6) P < 0.001). Moreover, cumulative dose variables of the following treatments were significantly associated with fertility impairment: busulfan, carmustine, cyclophosphamide, melphalan, procarbazine, lower abdominal RT and TBI. Busulfan, lower abdominal RT and TBI seem to be associated with fertility impairment at any dose, whereas gonadotoxicity of melphalan and procarbazine is suggested at medium/high (>140 mg/m2) or high dose (>5600 mg/m2) therapy, respectively. LIMITATIONS, REASONS FOR CAUTION Our study may have been subject to selection bias since data from about half of the original base cohorts were available for the current study. This could impact the generalizability of our study results. WIDER IMPLICATIONS OF THE FINDINGS We identified survivors at high risk for fertility impairment and, consequently, for a reduced or even absent reproductive life span. Both girls and young women who are about to start anti-cancer treatment, as well as adult female survivors, should be counselled about future parenthood and referred to a reproductive specialist for fertility preservation, if desired. STUDY FUNDING/COMPETING INTEREST(S) This study has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 602030. There are no competing interests. TRIAL REGISTRATION NUMBER n/a.
Collapse
Affiliation(s)
- M H van den Berg
- Department of Paediatrics, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - M van Dijk
- Department of Paediatrics, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - J Byrne
- Boyne Research Institute, Department of Epidemiology, Drogheda, Ireland
| | - C Berger
- Department of Pediatric Hematology and Oncology, University-Hospital, Saint-Etienne, France
| | - U Dirksen
- Department of Paediatric Haematology and Oncology, University Hospital Muenster, Muenster, Germany
| | - J F Winther
- Danish Cancer Society Research Center, Childhood Cancer Research Group, Copenhagen, Denmark.,Department of Clinical Medicine, Faculty of Health, Aarhus University and University Hospital, Aarhus, Denmark
| | - S D Fossa
- Department of Oncology, Oslo University Hospital, Oslo, Norway
| | - D Grabow
- German Childhood Cancer Registry (GCCR), Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany
| | | | - R Haupt
- Gaslini Children Hospital, Epidemiology and Biostatistics Section, Genova, Italy
| | - M M van den Heuvel-Eibrink
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.,Department of Paediatric Oncology, Sophia Children's Hospital, Rotterdam, The Netherlands
| | - M Kaiser
- German Childhood Cancer Registry (GCCR), Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany
| | - T Kepak
- University Hospital Brno, Brno, Czech Republic.,International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic
| | - A L F van der Kooi
- Department of Obstetrics and Gynecology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands
| | - L C M Kremer
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
| | - J Kruseova
- Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
| | - C B Lambalk
- Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam
| | - F E van Leeuwen
- Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, The Netherlands.,Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
| | - A Leiper
- Great Ormond Street Children's Hospital, London, UK
| | - D Modan-Moses
- Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Ramat Gan, Israel.,The Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel
| | - C Spix
- German Childhood Cancer Registry (GCCR), Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany
| | - J W R Twisk
- Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, THE Netherlands
| | - C M Ronckers
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.,Institute for Biostatistics and Registry Research, Medical University Brandenburg, Neuruppin, Germany
| | - P Kaatsch
- German Childhood Cancer Registry (GCCR), Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany
| | - E van Dulmen-den Broeder
- Department of Paediatrics, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | | |
Collapse
|
9
|
Scherf L, Kretschmann J, Fischer M, Mielenz N, Möbius G, Getto S, Kaiser M, Müller H, Bittner L, Baumgartner W, Starke A. [Thermographic monitoring of skin surface temperature associated with hot-iron disbudding in calves]. SCHWEIZ ARCH TIERH 2020; 162:174-184. [PMID: 32146437 DOI: 10.17236/sat00251] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
INTRODUCTION The goal of this study was to determine the skin surface temperatures of the head using thermography in 28 German Holstein heifer calves at the time of hot iron disbudding. Calves were divided into group 1 (hot-iron disbudding, n = 14) and 2 (sham disbudding, n = 14). Thermographic measurements were made at eight locations of the head (area surrounding both horn buds, both horn buds, muzzle, mucous membranes of the muzzle, both eyes) at nine time points (- 60 min (basal value), time of disbudding, 5, 30, 60, 90, 120, 240 and 480 min after disbudding) using a high-end thermographic camera (ThermoPro TP8, Firma DIAS Infrared GmbH). The rectal temperature was measured 60 min before and 5, 240 and 480 min after disbudding. The statistical software SAS version 9.4 was used for analysis. Skin surface temperatures and rectal temperature correlated at several locations (rp ≥ 0.45; p ≤ 0.05). The maximum temperature (approx. 67 ºC) was measured at the horn buds immediately after the hot-iron procedure. By five and 30 min after hot-iron disbudding, the temperature of the horn buds had decreased by up to 50%, whereas the temperatures at the other locations had increased significantly (p.
Collapse
Affiliation(s)
- L Scherf
- Klinik für Klauentiere der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - J Kretschmann
- Klinik für Klauentiere der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - M Fischer
- Institut für Tierhygiene und Öffentliches Veterinärwesen der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - N Mielenz
- Institut für -Agrar- und Ernährungswissenschaften, Arbeitsgruppe Biometrie und Agrarinformatik, Martin-Luther-Universität, Halle-Wittenberg, 06120 Halle (Saale), Deutschland
| | - G Möbius
- Institut für Tierhygiene und Öffentliches Veterinärwesen der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - S Getto
- Fraunhofer-Institut für Produktionstechnik und -Automatisierung, 70569 Stuttgart, Deutschland
| | - M Kaiser
- Klinik für Klauentiere der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - H Müller
- Klinik für Klauentiere der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - L Bittner
- Klinik für Klauentiere der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - W Baumgartner
- Universitätsklinik für Wiederkäuer, Veterinärmedizinische Universität Wien, 1210 Wien, Österreich
| | - A Starke
- Klinik für Klauentiere der Veterinärmedizinischen Fakultät der Universität Leipzig
| |
Collapse
|
10
|
Kaiser M, Schuhmann T, Werner S, Freund H. Multilevel reactor design for methanol synthesis. CHEM-ING-TECH 2020. [DOI: 10.1002/cite.202055215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- M. Kaiser
- Friedrich-Alexander-Universität Erlangen-Nürnberg Chemische Reaktionstechnik / Katalytische Reaktoren und Prozesstechnik Cauerstr. 3 91058 Erlangen Deutschland
| | - T. Schuhmann
- Air Liquide Global E&C Solutions Germany GmbH Olof-Palme-Str. 35 60439 Frankfurt am Main Germany
| | - S. Werner
- Clariant Produkte (Deutschland) GmbH BU Catalysts Semmelweißstr. 1 82152 Planegg Germany
| | - H. Freund
- Friedrich-Alexander-Universität Erlangen-Nürnberg Chemische Reaktionstechnik / Katalytische Reaktoren und Prozesstechnik Cauerstr. 3 91058 Erlangen Deutschland
| |
Collapse
|
11
|
van den Boom L, Kaiser M, Kostev K. Prevalence of insulin as a first-line therapy and associated factors in people with type 2 diabetes in German primary care practices. Diabet Med 2020; 37:1333-1339. [PMID: 32506471 DOI: 10.1111/dme.14338] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/02/2020] [Indexed: 12/16/2022]
Abstract
AIM To evaluate how many people with type 2 diabetes receive a treatment regimen with insulin as a first-line therapy and the factors associated with this. METHODS This retrospective study was based on data from the Disease Analyzer database and included 10 497 people with type 2 diabetes with an initial prescription of anti-hyperglycaemic therapy from 859 general and diabetologist practices in Germany between January 2014 and December 2018. The main outcome of the study was the prevalence of insulin as a first-line therapy. A multivariable logistic regression model was performed to investigate the association between predefined variables and the probability of receiving insulin as a first-line therapy. RESULTS A total of 7.1% of participants received insulin as a first-line therapy. Diabetologist practice [odds ratio (OR) 2.71, 95% confidence interval (CI) 1.81-4.06], age > 80 years (OR 2.35, 95% CI 1.20-4.61) compared with age ≤ 40 years, HbA1c ≥ 86 mmol/mol (10%) (OR 2.99, 95% CI 1.81-4.95) compared with HbA1c < 48 mmol/mol (6.5%), renal complications (OR 1.91, 95% CI 1.29-2.81), peripheral artery disease (OR 1.94, 95% CI 1.30-2.81), neurological complications (OR 1.45, 95% CI 1.00-2.09), Charlson Comorbidity Index (OR 1.16, 95% CI 1.08-1.25) and higher number of different drugs prescribed within 12 months prior-the index date (OR 1.09, 95% CI 1.05-1.12) were significantly associated with the probability of receiving insulin as a first-line therapy. CONCLUSION Insulin is rarely used as a first-line therapy in people with type 2 diabetes. Furthermore, a person's likelihood of receiving insulin as a first-line therapy is significantly influenced by diabetologist practice, age, HbA1c ≥ 86 mmol/mol (10%), renal, neurological and vascular complications, higher multimorbidity, and polypharmacy.
Collapse
Affiliation(s)
| | - M Kaiser
- Diabetologische Schwerpunktpraxis, Frankfurt, Germany
| | - K Kostev
- Epidemiology, IQVIA, Frankfurt, Germany
| |
Collapse
|
12
|
Scherf L, Kretschmann J, Fischer M, Mielenz N, Möbius G, Getto S, Kaiser M, Müller H, Bittner L, Starke A. [Thermographic examination of head surface temperatures of calves under field conditions]. SCHWEIZ ARCH TIERH 2020; 161:649-658. [PMID: 31586927 DOI: 10.17236/sat00227] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
INTRODUCTION Thermographic examination of 157 German Holstein heifer calves was performed to investigate the feasibility of this technique for on-farm recording of surface temperature of the head and to examine potential factors that affect the recordings. Baseline values were obtained from six defined locations on the head including both eyes, both horn buds, the muzzle and the mucous membrane of the muzzle using a high-end thermographic camera (ThermoPro TP8, Firma DIAS Infrared GmbH). Evaluation of the influence of various factors on thermographic measurements showed that ambient temperature had the largest effect on surface temperature of the head (regression coefficient, 0.10 to 0.32, p ≤ 0.01) whereas humidity had no effect (in t-test p ≥ 0.33 over all locations). There was a no correlation between rectal temperature and surface temperature (rp ≤ 0.05). The surface temperature decreased with increasing age of the calves (regression coefficient, - 0.42 to - 0.14, p ≤ 0.01). The agreement between double readings made shortly after one another was excellent at all locations (r ≥ 0.95). The emission of infrared energy varied among different locations; the most infrared energy was emitted by the eyes and the least by the muzzle. Paired locations (eyes and horn buds) had symmetric emission patterns of infrared energy. Measuring the surface temperature of the head of calves in their normal barn environment using a standardised protocol was feasible and thus could potentially be used for monitoring calves under field conditions.
Collapse
Affiliation(s)
- L Scherf
- Klinik für Klauentiere der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - J Kretschmann
- Klinik für Klauentiere der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - M Fischer
- Institut für Tierhygiene und Öffentliches Veterinärwesen der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - N Mielenz
- Institut für -Agrar- und Ernährungswissenschaften, Arbeitsgruppe Biometrie und Agrarinformatik, Martin-Luther-Universität, Halle-Wittenberg, 06120 Halle (Saale), Deutschland
| | - G Möbius
- Institut für Tierhygiene und Öffentliches Veterinärwesen der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - S Getto
- Fraunhofer-Institut für Produktionstechnik und -Automatisierung, 70569 Stuttgart, Deutschland
| | - M Kaiser
- Klinik für Klauentiere der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - H Müller
- Klinik für Klauentiere der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - L Bittner
- Klinik für Klauentiere der Veterinärmedizinischen Fakultät der Universität Leipzig
| | - A Starke
- Klinik für Klauentiere der Veterinärmedizinischen Fakultät der Universität Leipzig
| |
Collapse
|
13
|
Thomas C, Datta A, Kaiser M, Hutchings F. Towards modeling the influence of transcranial direct current stimulation on neuronal response. Brain Stimul 2019. [DOI: 10.1016/j.brs.2018.12.936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
14
|
Zinkler M, Beine KH, von Cranach M, Osterfeld M, Kaiser M, Weinmann S, Aderhold V. [Compulsory treatment with electroconvulsive therapy-scientifically unproven and questionable therapy with respect to human rights]. Nervenarzt 2018; 89:837-838. [PMID: 29926127 DOI: 10.1007/s00115-018-0558-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- M Zinkler
- Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Akademisches Lehrkrankenhaus der Universität Ulm, Kliniken Landkreis Heidenheim gGmbH, Schloßhaustraße 100, 89522, Heidenheim, Deutschland.
| | - K H Beine
- St. Marien-Hospital Hamm, Lehrstuhl für Psychiatrie und Psychotherapie, Universität Witten/Herdecke, Hamm, Deutschland
| | | | - M Osterfeld
- Unterausschuss zur Prävention von Folter und anderen grausamen unwürdigen oder erniedrigenden Behandlungen oder Strafen der Vereinten Nationen (UN SPT), Dortmund, Deutschland
| | - M Kaiser
- Klinik und Tagesklinik für Psychiatrie, Psychotherapie und Psychosomatik mit Psychiatrischer Institutsambulanz, Klinikum Merzig, Merzig, Deutschland
| | - S Weinmann
- Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Vivantes Klinikum Am Urban, Berlin, Deutschland
| | - V Aderhold
- Institut für Sozialpsychiatrie Mecklenburg-Vorpommern e. V, Greifswald, Deutschland
| |
Collapse
|
15
|
Nissle S, Kaiser M, Hübler M, Gurka M, Breuer U. Adaptive vortex generators based on active hybrid composites: from idea to flight test. ACTA ACUST UNITED AC 2018. [DOI: 10.1007/s13272-018-0316-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
16
|
Salazar C, Baumann D, Hänke T, Scheffler M, Kühne T, Kaiser M, Voigtländer R, Lindackers D, Büchner B, Hess C. An ultra-high vacuum scanning tunneling microscope operating at sub-Kelvin temperatures and high magnetic fields for spin-resolved measurements. Rev Sci Instrum 2018; 89:065104. [PMID: 29960518 DOI: 10.1063/1.5027782] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
We present the construction and performance of an ultra-low-temperature scanning tunneling microscope (STM), working in ultra-high vacuum (UHV) conditions and in high magnetic fields up to 9 T. The cryogenic environment of the STM is generated by a single-shot 3He magnet cryostat in combination with a 4He dewar system. At a base temperature (300 mK), the cryostat has an operation time of approximately 80 h. The special design of the microscope allows the transfer of the STM head from the cryostat to a UHV chamber system, where samples and STM tips can be easily exchanged. The UHV chambers are equipped with specific surface science treatment tools for the functionalization of samples and tips, including high-temperature treatments and thin film deposition. This, in particular, enables spin-resolved tunneling measurements. We present test measurements using well-known samples and tips based on superconductors and metallic materials such as LiFeAs, Nb, Fe, and W. The measurements demonstrate the outstanding performance of the STM with high spatial and energy resolution as well as the spin-resolved capability.
Collapse
Affiliation(s)
- C Salazar
- Leibniz Institute for Solid State and Materials Research, IFW-Dresden, Helmholtzstraße 20, 01069 Dresden, Germany
| | - D Baumann
- Leibniz Institute for Solid State and Materials Research, IFW-Dresden, Helmholtzstraße 20, 01069 Dresden, Germany
| | - T Hänke
- Leibniz Institute for Solid State and Materials Research, IFW-Dresden, Helmholtzstraße 20, 01069 Dresden, Germany
| | - M Scheffler
- Leibniz Institute for Solid State and Materials Research, IFW-Dresden, Helmholtzstraße 20, 01069 Dresden, Germany
| | - T Kühne
- Leibniz Institute for Solid State and Materials Research, IFW-Dresden, Helmholtzstraße 20, 01069 Dresden, Germany
| | - M Kaiser
- Leibniz Institute for Solid State and Materials Research, IFW-Dresden, Helmholtzstraße 20, 01069 Dresden, Germany
| | - R Voigtländer
- Leibniz Institute for Solid State and Materials Research, IFW-Dresden, Helmholtzstraße 20, 01069 Dresden, Germany
| | - D Lindackers
- Leibniz Institute for Solid State and Materials Research, IFW-Dresden, Helmholtzstraße 20, 01069 Dresden, Germany
| | - B Büchner
- Leibniz Institute for Solid State and Materials Research, IFW-Dresden, Helmholtzstraße 20, 01069 Dresden, Germany
| | - C Hess
- Leibniz Institute for Solid State and Materials Research, IFW-Dresden, Helmholtzstraße 20, 01069 Dresden, Germany
| |
Collapse
|
17
|
Kaiser M, Jacobson M, Andersen PH, Bækbo P, Cerón JJ, Dahl J, Escribano D, Jacobsen S. Correction to: Inflammatory markers before and after farrowing in healthy sows and in sows affected with postpartum dysgalactia syndrome. BMC Vet Res 2018; 14:175. [PMID: 29859077 PMCID: PMC5984813 DOI: 10.1186/s12917-018-1471-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- M Kaiser
- Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, Copenhagen University, Højbakkegård Alle 5, 2630, Taastrup, Denmark.
| | - M Jacobson
- Department of Clinical Sciences, Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences, p.o. Box 7054, SE-750 07, Uppsala, Sweden
| | - P H Andersen
- Department of Clinical Sciences, Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences, p.o. Box 7054, SE-750 07, Uppsala, Sweden
| | - P Bækbo
- SEGES, Danish Pig Research Center, Danish Agriculture & Food Council, Agro Food Park 15, 8200, Aarhus N, Denmark
| | - J J Cerón
- Department of Animal Medicine and Surgery, Regional "Campus of Excellence Mare Nostrum", University of Murcia, 30100 Espinardo, Murcia, Spain
| | - J Dahl
- Danish Agriculture and Food Council, Axelborg, Axeltorv 3, 1709, Copenhagen V, Denmark
| | - D Escribano
- Department of Animal Medicine and Surgery, Regional "Campus of Excellence Mare Nostrum", University of Murcia, 30100 Espinardo, Murcia, Spain
| | - S Jacobsen
- Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, Copenhagen University, Højbakkegård Alle 5, 2630, Taastrup, Denmark
| |
Collapse
|
18
|
Kunkel H, Mullen L, Robinson N, Thomas C, Morrow K, Kaiser M, Simakajornboon N. 1068 Utilizing Lean Methodology To Improve The Sleep Study Results Turnaround Process. Sleep 2018. [DOI: 10.1093/sleep/zsy061.1067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- H Kunkel
- Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - L Mullen
- Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - N Robinson
- Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - C Thomas
- Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - K Morrow
- Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - M Kaiser
- Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | | |
Collapse
|
19
|
Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M, Hajek R, Mohty M, Cavo M, Dimopoulos MA, San-Miguel JF, Terpos E, Zweegman S, Garderet L, Mateos MV, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk NWCJ, Waage A, Beksac M, Mellqvist UH, Engelhardt M, Caers J, Driessen C, Sonneveld P. Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network. Leukemia 2017:leu2017353. [PMID: 29251284 DOI: 10.1038/leu.2017.353] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2017] [Revised: 11/23/2017] [Accepted: 11/30/2017] [Indexed: 11/08/2022]
Abstract
During the last few years, several new drugs have been introduced for treatment of patients with multiple myeloma, which have significantly improved treatment outcome. All of these novel substances differ at least in part in their mode of action from similar drugs of the same drug class, or are representatives of new drugs classes, and as such present with very specific side effect profiles. In this review, we summarize these adverse events, provide information on their prevention, and give practical guidance for monitoring of patients and for management of adverse events.Leukemia accepted article preview online, 18 December 2017. doi:10.1038/leu.2017.353.
Collapse
Affiliation(s)
- H Ludwig
- Wilhelminen Cancer Research Institute, Vienna, Austria
| | - M Delforge
- Stem Cell Biology and Embryology Unit, Department of Development and Regeneration, Catholic University Leuven, Leuven, Belgium
| | - T Facon
- Department of Hematology, Lille University Hospital, Lille, France
| | - H Einsele
- Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany
| | - F Gay
- Myeloma Unit, Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy
| | - P Moreau
- Department of Hematology, University Hospital, University of Nantes, Nantes, France
| | - H Avet-Loiseau
- Centre de Recherches en Cancerologie de Toulouse CRCT, Institut National de la Sante et de la Recherche Medicale, Université Toulouse, Toulouse, France
| | - M Boccadoro
- Division of Hematology, Citta della Salute e della Scienza, University of Torino, Torino, Italy
| | - R Hajek
- Faculty of Medicine, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic
| | - M Mohty
- Department of Haematology, Saint Antoine Hospital, University Pierre and Marie Curie, and INSERM UMRs 938, Paris, France
| | - M Cavo
- a 'Seràgnoli' Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
| | - M A Dimopoulos
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - J F San-Miguel
- Department of Hematology, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona, Spain
| | - E Terpos
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - S Zweegman
- Department of Hematology, VU University Medical Center, Amsterdam, Netherlands
| | - L Garderet
- Department of Haematology, Saint Antoine Hospital, University Pierre and Marie Curie, and INSERM UMRs 938, Paris, France
| | - M-V Mateos
- Hospital Universitario de Salamanca, Instituto Biosanitario de Salamanca (IBSAL), Salamanca, Spain
| | - G Cook
- Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK
| | - X Leleu
- Service d'Hématologie et Thérapie Cellulaire, PRC, and Inserm CIC1402, Hospital de la Miléterie, Poitiers, France
| | - H Goldschmidt
- National Center for Tumor Diseases, Heidelberg Medical University, Heidelberg, Germany
| | - G Jackson
- Department of Hematology, Newcastle University, Newcastle, UK
| | - M Kaiser
- Myeloma Group, The Institute of Cancer Research ICR, London, UK
| | - K Weisel
- Department of Hematology and Oncology, University of Tuebingen, Tuebingen, Germany
| | - N W C J van de Donk
- Department of Hematology, VU University Medical Center, Amsterdam, Netherlands
| | - A Waage
- Department of Hematology, St Olavs Hospital, and IKOM, NTNU, Trondheim, Norway
| | - M Beksac
- Department of Medicine, Ankara University, Ankara, Turkey
| | - U H Mellqvist
- Department of Hematology Sahlgrenska Hospital, Gothenburg, Sweden
| | - M Engelhardt
- Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany
| | - J Caers
- Department of Hematology, University Hospital of Liège, Liège, Belgium
| | - C Driessen
- Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
| | - P Sonneveld
- Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
| |
Collapse
|
20
|
Dawidowski M, Emmanouilidis L, Kalel VC, Tripsianes K, Schorpp K, Hadian K, Kaiser M, Mäser P, Kolonko M, Tanghe S, Rodriguez A, Schliebs W, Erdmann R, Sattler M, Popowicz GM. Inhibitors of PEX14 disrupt protein import into glycosomes and kill Trypanosoma parasites. Science 2017; 355:1416-1420. [PMID: 28360328 DOI: 10.1126/science.aal1807] [Citation(s) in RCA: 45] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2016] [Accepted: 03/09/2017] [Indexed: 12/14/2022]
Abstract
The parasitic protists of the Trypanosoma genus infect humans and domestic mammals, causing severe mortality and huge economic losses. The most threatening trypanosomiasis is Chagas disease, affecting up to 12 million people in the Americas. We report a way to selectively kill Trypanosoma by blocking glycosomal/peroxisomal import that depends on the PEX14-PEX5 protein-protein interaction. We developed small molecules that efficiently disrupt the PEX14-PEX5 interaction. This results in mislocalization of glycosomal enzymes, causing metabolic catastrophe, and it kills the parasite. High-resolution x-ray structures and nuclear magnetic resonance data enabled the efficient design of inhibitors with trypanocidal activities comparable to approved medications. These results identify PEX14 as an "Achilles' heel" of the Trypanosoma suitable for the development of new therapies against trypanosomiases and provide the structural basis for their development.
Collapse
Affiliation(s)
- M Dawidowski
- Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany.,Center for Integrated Protein Science Munich at Chair of Biomolecular NMR, Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747 Garching, Germany
| | - L Emmanouilidis
- Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany.,Center for Integrated Protein Science Munich at Chair of Biomolecular NMR, Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747 Garching, Germany
| | - V C Kalel
- Institute of Biochemistry and Pathobiochemistry, Department of Systems Biochemistry, Faculty of Medicine, Ruhr University Bochum, 44780 Bochum, Germany
| | - K Tripsianes
- CEITEC, Central European Institute of Technology, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic
| | - K Schorpp
- Assay Development and Screening Platform, Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
| | - K Hadian
- Assay Development and Screening Platform, Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
| | - M Kaiser
- Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051 Basel, Switzerland.,University of Basel, 4001 Basel, Switzerland
| | - P Mäser
- Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051 Basel, Switzerland.,University of Basel, 4001 Basel, Switzerland
| | - M Kolonko
- Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
| | - S Tanghe
- New York University School of Medicine, Department of Microbiology, 341 East 25th Street, Room 513, New York, NY 10010, USA
| | - A Rodriguez
- New York University School of Medicine, Department of Microbiology, 341 East 25th Street, Room 513, New York, NY 10010, USA
| | - W Schliebs
- Institute of Biochemistry and Pathobiochemistry, Department of Systems Biochemistry, Faculty of Medicine, Ruhr University Bochum, 44780 Bochum, Germany
| | - R Erdmann
- Institute of Biochemistry and Pathobiochemistry, Department of Systems Biochemistry, Faculty of Medicine, Ruhr University Bochum, 44780 Bochum, Germany.
| | - M Sattler
- Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany. .,Center for Integrated Protein Science Munich at Chair of Biomolecular NMR, Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747 Garching, Germany
| | - G M Popowicz
- Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany. .,Center for Integrated Protein Science Munich at Chair of Biomolecular NMR, Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747 Garching, Germany
| |
Collapse
|
21
|
Greve H, Kaiser M, Brun R, Schmidt TJ. Antiplasmodial leads in oleo-gum-resins from Burseraceae: bioactivity-guided fractionation of myrrh. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- H Greve
- Institute for Pharmaceutical Biology and Phytochemistry (IPBP), WWU Münster, Münster, Germany
| | - M Kaiser
- Swiss Tropical and Public Health Institute (Swiss TPH), Basle, Switzerland
- University of Basle, Basle, Switzerland
| | - R Brun
- Swiss Tropical and Public Health Institute (Swiss TPH), Basle, Switzerland
- University of Basle, Basle, Switzerland
| | - TJ Schmidt
- Institute for Pharmaceutical Biology and Phytochemistry (IPBP), WWU Münster, Münster, Germany
| |
Collapse
|
22
|
Bernal F, Kaiser M, Schmidt T. Synthesis and docking studies of dihydrobenzofuran neolignan analogues as antileishmanial agents. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- F Bernal
- Institut für Pharmazeutische Biologie und Phytochemie (IPBP), University of Münster, Münster, Germany
| | - M Kaiser
- Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland
- University of Basel, Basel, Switzerland
| | - T Schmidt
- Institut für Pharmazeutische Biologie und Phytochemie (IPBP), University of Münster, Münster, Germany
| |
Collapse
|
23
|
Greve H, Kaiser M, Brun R, Schmidt TJ. Search for new antiplasmodial leads in the oleo-gum-resin of Boswellia serrata Roxb. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- H Greve
- Institute for Pharmaceutical Biology and Phytochemistry (IPBP), WWU Münster, Münster, Germany
| | - M Kaiser
- Swiss Tropical and Public Health Institute (Swiss TPH), Basle, Switzerland
- University of Basle, Basle, Switzerland
| | - R Brun
- Swiss Tropical and Public Health Institute (Swiss TPH), Basle, Switzerland
- University of Basle, Basle, Switzerland
| | - TJ Schmidt
- Institute for Pharmaceutical Biology and Phytochemistry (IPBP), WWU Münster, Münster, Germany
| |
Collapse
|
24
|
Kimani N, Matasyoh J, Kaiser M, Brun R, Schmidt T. ANTIPROTOZOAL SESQUITERPENE LACTONES AND OTHER CONSTITUENTS FROM Schkuhria pinnata, Tarchonanthus camphoratus AND Vernonia lasiopus. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- N Kimani
- Institute of Pharmaceutical Biology and Phytochemistry (IPBP), University of Münster, PharmaCampus, Corrensstraße 48, Münster D-48149, münster, Germany
| | - J Matasyoh
- Department of Chemistry, Egerton University, P.O. Box 536, Egerton 20115, Egerton, Kenya
| | - M Kaiser
- Swiss Tropical and Public Health Institute (Swiss TPH), Socinstr. 57, Basel CH-4051, Basel, Switzerland
- University of Basel, Petersplatz 1, Basel CH-4003, Basel, Switzerland
| | - R Brun
- Swiss Tropical and Public Health Institute (Swiss TPH), Socinstr. 57, Basel CH-4051, Basel, Switzerland
- University of Basel, Petersplatz 1, Basel CH-4003, Basel, Switzerland
| | - T Schmidt
- Institute of Pharmaceutical Biology and Phytochemistry (IPBP), University of Münster, PharmaCampus, Corrensstraße 48, Münster D-48149, münster, Germany
| |
Collapse
|
25
|
Nnadi CO, Nwodo NJ, Kaiser M, Brun R, Schmidt Thomas J. STEROIDAL ALKALOIDS AS POTENT AGENTS AGAINST Trypanosoma brucei rhodesiense. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- CO Nnadi
- Institute of Pharmaceutical Biology and Phytochemistry (IPBP), University of Münster, PharmaCampus,Corrensstraße 48, D-48149, Münster, Germany
- Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Nigeria Nsukka, 40001 Nsukka, Enugu State, Nigeria
| | - NJ Nwodo
- Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Nigeria Nsukka, 40001 Nsukka, Enugu State, Nigeria
| | - M Kaiser
- Swiss Tropical and Public Health Institute (Swiss TPHI), Basel, Switzerland
- University of Basel, Socinstr. 57, Basel CH-4051, Basel, Switzerland
| | - R Brun
- Swiss Tropical and Public Health Institute (Swiss TPHI), Basel, Switzerland
- University of Basel, Socinstr. 57, Basel CH-4051, Basel, Switzerland
| | - J Schmidt Thomas
- Institute of Pharmaceutical Biology and Phytochemistry (IPBP), University of Münster, PharmaCampus,Corrensstraße 48, D-48149, Münster, Germany
| |
Collapse
|
26
|
Mahmoud A, Mäser P, Kaiser M, Hamburger M, Khalid S. Screening of Selected Sudanese Medicinal Plants for In vitro Activity Against Protozoal Neglected Tropical Diseases. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608461] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- A Mahmoud
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland
- Faculty of Pharmacy, University of Khartoum, Khartoum, Sudan
| | - P Mäser
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland
| | - M Kaiser
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland
| | - M Hamburger
- Department of Pharmaceutical Biology, University of Basel, Basel, Switzerland
| | - S Khalid
- Faculty of Pharmacy, University of Khartoum, Khartoum, Sudan
- Faculty of Pharmacy, University of Science and Technology, Omdurman, Sudan
| |
Collapse
|
27
|
Nejad Ebrahimi S, Hashempour H, Herfati F, Valizadeh H, Mahmoudi-Kordi F, Kaiser M, Hamburger M. Diterpenoids from Astrodaucus orientalis (L.) Drude - Antiprotozoal activity. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- S Nejad Ebrahimi
- Department of Phytochemistry, Medicinal Plants and Drug Research Institute, Shahid Beheshti University, G. C, Tehran, Iran
| | - H Hashempour
- Department of Chemistry, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran
| | - F Herfati
- Department of Chemistry, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran
| | - H Valizadeh
- Department of Chemistry, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran
| | - F Mahmoudi-Kordi
- Department of Biology, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran
| | - M Kaiser
- Swiss Tropical and Public Health Institute, Socinstrasse 57, 4002, Basel, Switzerland
| | - M Hamburger
- Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056, Basel, Switzerland
| |
Collapse
|
28
|
Affiliation(s)
- H.S. Scheer
- Department of Surgery, Limmattal Hospital, Zurich-Schlieren, Switzerland
| | - M. Kaiser
- Department of Surgery, Limmattal Hospital, Zurich-Schlieren, Switzerland
| | - U. Zingg
- Department of Surgery, Limmattal Hospital, Zurich-Schlieren, Switzerland
| |
Collapse
|
29
|
Kaiser M, Glaesmer H. TRAJECTORIES OF TRAUMA-RELATED DISORDERS ACROSS THE LIFE-SPAN: EVIDENCE AND CLINICAL IMPLICATIONS. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- M. Kaiser
- Medical Psychology and Medical Sociology, Leipzig University, Leipzig, Germany
| | - H. Glaesmer
- Medical Psychology and Medical Sociology, Leipzig University, Leipzig, Germany
| |
Collapse
|
30
|
Went M, Sud A, Law PJ, Johnson DC, Weinhold N, Försti A, van Duin M, Mitchell JS, Chen B, Kuiper R, Stephens OW, Bertsch U, Campo C, Einsele H, Gregory WM, Henrion M, Hillengass J, Hoffmann P, Jackson GH, Lenive O, Nickel J, Nöthen MM, da Silva Filho MI, Thomsen H, Walker BA, Broyl A, Davies FE, Langer C, Hansson M, Kaiser M, Sonneveld P, Goldschmidt H, Hemminki K, Nilsson B, Morgan GJ, Houlston RS. Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach. Blood Cancer J 2017; 7. [PMID: 28622301 PMCID: PMC5520395 DOI: 10.1038/bcj.2017.48] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Affiliation(s)
- M Went
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
- Division of Molecular Pathology, The Institute of Cancer Research, London, UK
| | - A Sud
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
| | - P J Law
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
| | - D C Johnson
- Division of Molecular Pathology, The Institute of Cancer Research, London, UK
| | - N Weinhold
- Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA
- Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
| | - A Försti
- Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
- Center for Primary Health Care Research, Lund University, Malmo, Sweden
| | - M van Duin
- Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
| | - J S Mitchell
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
| | - B Chen
- Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
| | - R Kuiper
- Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
| | - O W Stephens
- Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | - U Bertsch
- Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
- National Center for Tumor Diseases, Heidelberg, Germany
| | - C Campo
- Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
| | - H Einsele
- Department of Internal Medicine II, Division of Hematology and Medical Oncology, University Hospital Würzburg, Würzburg, Germany
| | - W M Gregory
- Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
| | - M Henrion
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
| | - J Hillengass
- Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
| | - P Hoffmann
- Institute of Human Genetics, University of Bonn, Bonn, Germany
- Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland
| | - G H Jackson
- Royal Victoria Infirmary, Newcastle upon Tyne, Newcastle, UK
| | - O Lenive
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
| | - J Nickel
- Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
| | - M M Nöthen
- Institute of Human Genetics, University of Bonn, Bonn, Germany
- Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany
| | - M I da Silva Filho
- Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
| | - H Thomsen
- Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
| | - B A Walker
- Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | - A Broyl
- Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
| | - F E Davies
- Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | - C Langer
- Department of Internal Medicine III, University of Ulm, Ulm, Germany
| | - M Hansson
- Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden
- Hematology Clinic, Skåne University Hospital, Lund, Sweden
| | - M Kaiser
- Division of Molecular Pathology, The Institute of Cancer Research, London, UK
| | - P Sonneveld
- Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
| | - H Goldschmidt
- Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
- National Center for Tumor Diseases, Heidelberg, Germany
| | - K Hemminki
- Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
- Center for Primary Health Care Research, Lund University, Malmo, Sweden
| | - B Nilsson
- Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden
- Clinical Immunology and Transfusion Medicine, Laboratory Medicine, Office of Medical Services, Lund, Sweden
- Broad Institute, 7 Cambridge Center, Cambridge, MA, USA
| | - G J Morgan
- Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | - R S Houlston
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
- E-mail:
| |
Collapse
|
31
|
Kuhnl A, Shaikh R, Cunningham D, Counsell N, Barrans S, Burton C, Bentley M, Gleeson M, Edwards L, Ulrich L, Smith P, Clifton-Hadley L, Schofield O, Lawrie A, Linch D, Hubank M, Kaiser M. DNMT3A-2
EXPRESSION LEVELS CHARACTERISE DIFFUSE LARGE B-CELL LYMPHOMA WITH DISTINCT METHYLATION PATTERNS AND OUTCOME. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- A. Kuhnl
- Department of Medicine; Royal Marsden Hospital; London UK
| | - R. Shaikh
- Centre for Molecular Pathology; Royal Marsden Hospital; London UK
| | - D. Cunningham
- Department of Medicine; Royal Marsden Hospital; London UK
| | - N. Counsell
- Cancer Research UK and UCL Cancer Trials Centre; University College London; London UK
| | - S. Barrans
- HMDS St James's Institute of Oncology; St James's University Hospital; Leeds UK
| | - C. Burton
- HMDS St James's Institute of Oncology; St James's University Hospital; Leeds UK
| | - M. Bentley
- HMDS St James's Institute of Oncology; St James's University Hospital; Leeds UK
| | - M. Gleeson
- Department of Medicine; Royal Marsden Hospital; London UK
| | - L. Edwards
- Department of Medicine; Royal Marsden Hospital; London UK
| | - L. Ulrich
- Department of Medicine; Royal Marsden Hospital; London UK
| | - P. Smith
- Cancer Research UK and UCL Cancer Trials Centre; University College London; London UK
| | - L. Clifton-Hadley
- Cancer Research UK and UCL Cancer Trials Centre; University College London; London UK
| | - O. Schofield
- Cancer Research UK and UCL Cancer Trials Centre; University College London; London UK
| | - A. Lawrie
- Cancer Research UK and UCL Cancer Trials Centre; University College London; London UK
| | - D. Linch
- Department of Hematology; University College London; London UK
| | - M. Hubank
- Centre for Molecular Pathology; Royal Marsden Hospital; London UK
| | - M. Kaiser
- Division of Molecular Pathology; The Institute of Cancer Research; Sutton UK
| |
Collapse
|
32
|
Kern W, Kaiser M, Bailey TS, Takacs R, Rao PV, Tsoukas GM, Rieck M, Christensen SB, Kaltoft MS, Maislos M. Wirksamkeit und Sicherheit der Umstellung von Sitagliptin (SITA) auf Liraglutid (LIRA) bei Menschen mit Typ 2 Diabetes (T2D) und unzureichender Blutzuckereinstellung mit SITA und Metformin (MET): Post-Hoc-Analyse der Subgruppen mit einem Baseline-BMI < oder ≥30 kg/m2. DIABETOL STOFFWECHS 2017. [DOI: 10.1055/s-0037-1601786] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- W Kern
- MVZ 'Endokrinologikum' Ulm, Zentrum für Hormon- und Stoffwechselerkrankungen, Ulm, Germany
| | - M Kaiser
- Diabetologische Schwerpunktpraxis, Frankfurt, Germany
| | - TS Bailey
- AMCR Institute Inc., Escondido, United States
| | - R Takacs
- University of Szeged, First Department of Medicine, Szeged, Hungary
| | - PV Rao
- Nizam's Institute of Medical Sciences University, Hyderabad, India
| | - GM Tsoukas
- McGill University, Royal Victoria Hospital, Montreal, Canada
| | - M Rieck
- Novo Nordisk Pharma GmbH, Mainz, Germany
| | | | | | - M Maislos
- Ben Gurion University of the Negev, Beer Sheva, Israel
| |
Collapse
|
33
|
Würth C, Kaiser M, Wilhelm S, Grauel B, Hirsch T, Resch-Genger U. Excitation power dependent population pathways and absolute quantum yields of upconversion nanoparticles in different solvents. Nanoscale 2017; 9:4283-4294. [PMID: 28294258 DOI: 10.1039/c7nr00092h] [Citation(s) in RCA: 52] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
The rational design of brighter upconversion nanoparticles (UCNPs) requires a better understanding of the radiationless deactivation pathways in these materials. Here, we demonstrate the potential of excitation power density (P)-dependent studies of upconversion (UC) luminescence intensities, slope factors, and absolute quantum yields (ΦUC) of popular β-NaYF4:20% Yb3+,2% Er3+ UCNPs of different surface chemistries in organic solvents, D2O, and water as a tool to gain deeper insight into the UC mechanism including population and deactivation pathways particularly of the red emission. Our measurements, covering a P regime of three orders of magnitude, reveal a strong difference of the P-dependence of the ratio of the green and red luminescence bands (Ig/r) in water and organic solvents and P-dependent population pathways of the different emissive energy levels of Er3+. In summary, we provide experimental evidence for three photon processes in UCNPs, particularly for the red emission. Moreover, we demonstrate changes in the excited population dynamics via bi- and triphotonic processes dependent on the environment, surface chemistry, and P, and validate our findings theoretically.
Collapse
Affiliation(s)
- C Würth
- BAM Federal Institute for Materials Research and Testing, Division 1.10 Biophotonics, Richard-Willstaetter-Str. 11, 12489 Berlin, Germany.
| | - M Kaiser
- BAM Federal Institute for Materials Research and Testing, Division 1.10 Biophotonics, Richard-Willstaetter-Str. 11, 12489 Berlin, Germany.
| | - S Wilhelm
- Institute of Analytical Chemistry, Chemo- and Biosensors, University of Regensburg, 93040 Regensburg, Germany
| | - B Grauel
- BAM Federal Institute for Materials Research and Testing, Division 1.10 Biophotonics, Richard-Willstaetter-Str. 11, 12489 Berlin, Germany.
| | - T Hirsch
- Institute of Analytical Chemistry, Chemo- and Biosensors, University of Regensburg, 93040 Regensburg, Germany
| | - U Resch-Genger
- BAM Federal Institute for Materials Research and Testing, Division 1.10 Biophotonics, Richard-Willstaetter-Str. 11, 12489 Berlin, Germany.
| |
Collapse
|
34
|
Han X, Sawada T, Ebert R, Wiest T, Kaiser M, Geis-Gerstorfer J, Spintzyk S. Manufacturing process influence on Co–Cr base-alloy mechanical properties. Dent Mater 2017. [DOI: 10.1016/j.dental.2017.08.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
35
|
Abstract
Mesenchymal stem cells differentiate into multiple types of cells derived from mesenchyme. Periodontal ligament cells are primarily derived from mesenchyme; thus, we expected mesenchymal stem cells to differentiate into periodontal ligament. Using a combination of immunohistochemistry and in situ hybridization on co-cultures of mesenchymal stem cells and periodontal ligament, we observed a significant increase in mesenchymal stem cells’ expression of osteocalcin and osteopontin and a significant decrease in expression of bone sialoprotein, characteristics of periodontal ligament in vivo. Increased osteopontin and osteocalcin and decreased bone sialoprotein expression was detected within 7 days and maintained through 21 days of co-culture. We conclude that contact or factors from periodontal ligament induced mesenchymal stem cells to obtain periodontal-ligament-like characteristics. Importantly, analysis of the data suggests the feasibility of utilizing mesenchymal stem cells in clinical applications for repairing and/or regenerating periodontal tissue.
Collapse
Affiliation(s)
- P R Kramer
- Department of Biomedical Sciences, Baylor College of Dentistry, Texas A&M University System Health Science Center, 3302 Gaston Ave., Dallas, TX 75246, USA.
| | | | | | | | | |
Collapse
|
36
|
D’Angelo D, Agostini M, Altenmüller K, Appel S, Bellini G, Benziger J, Bick D, Bonfini G, Bravo D, Caccianiga B, Calaprice F, Caminata A, Cavalcante P, Chepurnov A, Davini S, Derbin A, Di Noto L, Drachnev I, Etenko A, Fomenko K, Franco D, Gabriele F, Galbiati C, Ghiano C, Giammarchi M, Goeger-Neff M, Goretti A, Gromov M, Hagner C, Hungerford E, Ianni A, Ianni A, Jedrzejczak K, Kaiser M, Kobychev V, Korablev D, Korga G, Kryn D, Laubenstein M, Lehnert B, Litvinovich E, Lombardi F, Lombardi P, Ludhova L, Lukyanchenko G, Machulin I, Manecki S, Maneschg W, Marcocci S, Meroni E, Meyer M, Miramonti L, Misiaszek M, Montuschi M, Mosteiro P, Muratova V, Neumair B, Oberauer L, Obolensky M, Ortica F, Pallavicini M, Papp L, Perasso L, Pocar A, Ranucci G, Razeto A, Re A, Romani A, Roncin R, Rossi N, Schönert S, Semenov D, Simgen H, Skorokhvatov M, Smirnov O, Sotnikov A, Sukhotin S, Suvorov Y, Tartaglia R, Testera G, Thurn J, Toropova M, Unzhakov E, Vishneva A, Vogelaar R, von Feilitzsch F, Wang H, Weinz S, Winter J, Wojcik M, Wurm M, Yokley Z, Zaimidoroga O, Zavatarelli S, Zuber K, Zuzel G. Recent Borexino results and prospects for the near future. EPJ Web Conf 2016. [DOI: 10.1051/epjconf/201612602008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
37
|
Kuźma Ł, Kaiser M, Wysokińska H. The production and antiprotozoal activity of abietane diterpenes in Salvia austriaca hairy roots grown in shake flasks and bioreactor. Prep Biochem Biotechnol 2016; 47:58-66. [DOI: 10.1080/10826068.2016.1168745] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- Ł. Kuźma
- Department of Biology and Pharmaceutical Botany, Medical University of Łódź, Łódź, Poland
| | - M. Kaiser
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Medical Parasitology and Infection Biology, Basel, Switzerland
- University of Basel, Basel, Switzerland
| | - H. Wysokińska
- Department of Biology and Pharmaceutical Botany, Medical University of Łódź, Łódź, Poland
| |
Collapse
|
38
|
Jaehn T, Müller LK, Hauer N, Blank B, Kaiser M, Reichert B. [Secondary plastic and reconstructive measures following deep-dermal burn injuries : Negligent use of bioethanol]. Unfallchirurg 2016; 120:167-170. [PMID: 27757484 DOI: 10.1007/s00113-016-0258-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
One representative case of burns caused by the negligent use of bioethanol, which was treated at our burns centre is used to illustrate the severity and depth of the burn injuries as well as the complexity of the further long-term course of treatment including complex secondary-reconstructive techniques.
Collapse
Affiliation(s)
- T Jaehn
- Universitätsklinik für Plastische, Wiederherstellende und Handchirurgie, Zentrum für Schwerbrandverletzte, Paracelsus Medizinische Privatuniversität, Klinikum Nürnberg Süd, Breslauer Straße 201, 90471, Nürnberg, Deutschland.
| | - L-K Müller
- Universitätsklinik für Plastische, Wiederherstellende und Handchirurgie, Zentrum für Schwerbrandverletzte, Paracelsus Medizinische Privatuniversität, Klinikum Nürnberg Süd, Breslauer Straße 201, 90471, Nürnberg, Deutschland
| | - N Hauer
- Universitätsklinik für Plastische, Wiederherstellende und Handchirurgie, Zentrum für Schwerbrandverletzte, Paracelsus Medizinische Privatuniversität, Klinikum Nürnberg Süd, Breslauer Straße 201, 90471, Nürnberg, Deutschland
| | - B Blank
- Universitätsklinik für Plastische, Wiederherstellende und Handchirurgie, Zentrum für Schwerbrandverletzte, Paracelsus Medizinische Privatuniversität, Klinikum Nürnberg Süd, Breslauer Straße 201, 90471, Nürnberg, Deutschland
| | - M Kaiser
- Universitätsklinik für Plastische, Wiederherstellende und Handchirurgie, Zentrum für Schwerbrandverletzte, Paracelsus Medizinische Privatuniversität, Klinikum Nürnberg Süd, Breslauer Straße 201, 90471, Nürnberg, Deutschland
| | - B Reichert
- Universitätsklinik für Plastische, Wiederherstellende und Handchirurgie, Zentrum für Schwerbrandverletzte, Paracelsus Medizinische Privatuniversität, Klinikum Nürnberg Süd, Breslauer Straße 201, 90471, Nürnberg, Deutschland
| |
Collapse
|
39
|
|
40
|
Hurtado FK, Kaiser M, Tasso L, Dalla Costa T. Fast and Sensitive RP-HPLC—Fluorescence Method for the Quantitative Analysis of Moxifloxacin in Rat Plasma and Its Application to a Preclinical Pharmacokinetic Study. ACTA CHROMATOGR 2016. [DOI: 10.1556/1326.2016.28.2.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
41
|
Kaiser M, Kretzschmar Y, Kienhöfer J, Gautier JF, Penfornis A, Charpentier G, Martinez L, Eschwège E, Gourdy P. Der Anteil der Patienten, die mit Liraglutid erfolgreich behandelt wurden – Ergebnisse einer Post-hoc-Analyse der EVIDENCE-Studie. DIABETOL STOFFWECHS 2016. [DOI: 10.1055/s-0036-1580966] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
42
|
Johnson DC, Weinhold N, Mitchell J, Chen B, Stephens OW, Försti A, Nickel J, Kaiser M, Gregory WA, Cairns D, Jackson GH, Hoffmann P, Noethen MM, Hillengass J, Bertsch U, Barlogie B, Davis FE, Hemminki K, Goldschmidt H, Houlston RS, Morgan GJ. Genetic factors influencing the risk of multiple myeloma bone disease. Leukemia 2016; 30:883-8. [PMID: 26669972 PMCID: PMC4832071 DOI: 10.1038/leu.2015.342] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2015] [Revised: 11/25/2015] [Accepted: 11/30/2015] [Indexed: 01/18/2023]
Abstract
A major complication of multiple myeloma (MM) is the development of osteolytic lesions, fractures and bone pain. To identify genetic variants influencing the development of MM bone disease (MBD), we analyzed MM patients of European ancestry (totaling 3774), which had been radiologically surveyed for MBD. Each patient had been genotyped for ~6 00 000 single-nucleotide polymorphisms with genotypes for six million common variants imputed using 1000 Genomes Project and UK10K as reference. We identified a locus at 8q24.12 for MBD (rs4407910, OPG/TNFRSF11B, odds ratio=1.38, P=4.09 × 10(-9)) and a promising association at 19q13.43 (rs74676832, odds ratio=1.97, P=9.33 × 10(-7)). Our findings demonstrate that germline variation influences MBD and highlights the importance of RANK/RANKL/OPG pathway in MBD development. These findings will contribute to the development of future strategies for prevention of MBD in the early precancerous phases of MM.
Collapse
Affiliation(s)
- D C Johnson
- Division of Molecular Pathology, The Institute of Cancer Research, London, UK
| | - N Weinhold
- Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
- Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
| | - J Mitchell
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
| | - B Chen
- German Cancer Research Center, Heidelberg, Germany
| | - O W Stephens
- Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | - A Försti
- German Cancer Research Center, Heidelberg, Germany
- Center for Primary Health Care Research, Lund University, Malmö, Sweden
| | - J Nickel
- Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
| | - M Kaiser
- Division of Molecular Pathology, The Institute of Cancer Research, London, UK
| | - W A Gregory
- Leeds Institute of Molecular Medicine, Section of Clinical Trials Research, University of Leeds, Leeds, UK
| | - D Cairns
- Leeds Institute of Molecular Medicine, Section of Clinical Trials Research, University of Leeds, Leeds, UK
| | - G H Jackson
- Department of Haematology, Newcastle University, Newcastle-Upon-Tyne, UK
| | - P Hoffmann
- Institute of Human Genetics, University of Bonn, Bonn, Germany
- Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland
| | - M M Noethen
- Institute of Human Genetics, University of Bonn, Bonn, Germany
- Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany
| | - J Hillengass
- Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
| | - U Bertsch
- Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
| | - B Barlogie
- Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | - F E Davis
- Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | - K Hemminki
- German Cancer Research Center, Heidelberg, Germany
- Center for Primary Health Care Research, Lund University, Malmö, Sweden
| | - H Goldschmidt
- Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
- National Center of Tumor Diseases, Heidelberg, Germany
| | - R S Houlston
- Division of Molecular Pathology, The Institute of Cancer Research, London, UK
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
| | - G J Morgan
- Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
| |
Collapse
|
43
|
Henríquez P, Kaiser M, Bohle H, Bustos P, Mancilla M. Comprehensive antibiotic susceptibility profiling of Chilean Piscirickettsia salmonis field isolates. J Fish Dis 2016; 39:441-8. [PMID: 26660665 DOI: 10.1111/jfd.12427] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/15/2015] [Revised: 09/30/2015] [Accepted: 09/30/2015] [Indexed: 05/12/2023]
Abstract
Antibiotics have been extensively used against infections produced by Piscirickettsia salmonis, a fish pathogen and causative agent of piscirickettsiosis and one of the major concerns for the Chilean salmon industry. Therefore, the emergence of resistant phenotypes is to be expected. With the aim of obtaining a landscape of the antimicrobial resistance of P. salmonis in Chile, the susceptibility profiles for quinolones, florfenicol and oxytetracycline (OTC) of 292 field isolates derived from main rearing areas, different hosts and collected over 5 years were assessed. The results allowed for the determination of epidemiological cut-off values that were used to characterize the pathogen population. This work represents the first large-scale field study addressing the antimicrobial susceptibility of P. salmonis, providing evidence of the existence of resistant types with a high incidence of resistance to quinolones. Remarkably, despite the amounts and frequency of therapies, our results disclosed that the issue of resistance to florfenicol and OTC is still in the onset.
Collapse
Affiliation(s)
- P Henríquez
- Laboratorio de Diagnóstico y Biotecnología, ADL Diagnostic Chile Ltda, Puerto Montt, Chile
| | - M Kaiser
- Rudolf Boehm Institute of Pharmacology and Toxicology, Medical Faculty, University of Leipzig, Leipzig, Germany
| | - H Bohle
- Laboratorio de Diagnóstico y Biotecnología, ADL Diagnostic Chile Ltda, Puerto Montt, Chile
| | - P Bustos
- Laboratorio de Diagnóstico y Biotecnología, ADL Diagnostic Chile Ltda, Puerto Montt, Chile
| | - M Mancilla
- Laboratorio de Diagnóstico y Biotecnología, ADL Diagnostic Chile Ltda, Puerto Montt, Chile
| |
Collapse
|
44
|
Caminata A, Agostini M, Altenmüller K, Appel S, Bellini G, Benziger J, Berton N, Bick D, Bonfini G, Bravo D, Caccianiga B, Calaprice F, Cavalcante P, Chepurnov A, Cribier M, D'Angelo D, Davini S, Derbin A, Noto LD, Durero M, Empl A, Etenko A, Farinon S, Fischer V, Fomenko K, Franco D, Gabriele F, Gaffiot J, Galbiati C, Ghiano C, Giammarchi M, Göger-Neff M, Goretti A, Gromov M, Hagner C, Houdy T, Hungerford E, Ianni A, Ianni A, Jonquères N, Kaiser M, Kobychev V, Korablev D, Korga G, Kryn D, Lachenmaier T, Lasserre T, Laubenstein M, Lehnert B, Link J, Litvinovich E, Lombardi F, Lombardi P, Ludhova L, Lukyanchenko G, Machulin I, Maneschg W, Marcocci S, Maricic J, Mention G, Meroni E, Meyer M, Miramonti L, Misiaszek M, Montuschi M, Muratova V, Musenich R, Neumair B, Oberauer L, Obolensky M, Ortica F, Pallavicini M, Papp L, Perasso L, Pocar A, Ranucci G, Razeto A, Re A, Romani A, Rossi N, Schönert S, Scola L, Simgen H, Skorokhvatov M, Smirnov O, Sotnikov A, Sukhotin S, Suvorov Y, Tartaglia R, Testera G, Veyssière C, Vivier M, Vogelaar R, Feilitzsch FV, Wang H, Winter J, Wojcik M, Wurm M, Zaimidoroga O, Zavatarelli S, Zuber K, Zuzel G. Short distance neutrino oscillations with Borexino. EPJ Web of Conferences 2016. [DOI: 10.1051/epjconf/201612101002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
45
|
Agostini M, Appel S, Bellini G, Benziger J, Bick D, Bonfini G, Bravo D, Caccianiga B, Calaprice F, Caminata A, Cavalcante P, Chepurnov A, D'Angelo D, Davini S, Derbin A, Di Noto L, Drachnev I, Empl A, Etenko A, Fomenko K, Franco D, Gabriele F, Galbiati C, Ghiano C, Giammarchi M, Goeger-Neff M, Goretti A, Gromov M, Hagner C, Hungerford E, Ianni A, Ianni A, Jedrzejczak K, Kaiser M, Kobychev V, Korablev D, Korga G, Kryn D, Laubenstein M, Lehnert B, Litvinovich E, Lombardi F, Lombardi P, Ludhova L, Lukyanchenko G, Machulin I, Manecki S, Maneschg W, Marcocci S, Meroni E, Meyer M, Miramonti L, Misiaszek M, Montuschi M, Mosteiro P, Muratova V, Neumair B, Oberauer L, Obolensky M, Ortica F, Otis K, Pallavicini M, Papp L, Perasso L, Pocar A, Ranucci G, Razeto A, Re A, Romani A, Roncin R, Rossi N, Schönert S, Semenov D, Simgen H, Skorokhvatov M, Smirnov O, Sotnikov A, Sukhotin S, Suvorov Y, Tartaglia R, Testera G, Thurn J, Toropova M, Unzhakov E, Vishneva A, Vogelaar RB, von Feilitzsch F, Wang H, Weinz S, Winter J, Wojcik M, Wurm M, Yokley Z, Zaimidoroga O, Zavatarelli S, Zuber K, Zuzel G. Test of Electric Charge Conservation with Borexino. Phys Rev Lett 2015; 115:231802. [PMID: 26684111 DOI: 10.1103/physrevlett.115.231802] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/03/2015] [Indexed: 06/05/2023]
Abstract
Borexino is a liquid scintillation detector located deep underground at the Laboratori Nazionali del Gran Sasso (LNGS, Italy). Thanks to the unmatched radio purity of the scintillator, and to the well understood detector response at low energy, a new limit on the stability of the electron for decay into a neutrino and a single monoenergetic photon was obtained. This new bound, τ≥6.6×10^{28} yr at 90% C.L., is 2 orders of magnitude better than the previous limit.
Collapse
Affiliation(s)
- M Agostini
- Physik-Department and Excellence Cluster Universe, Technische Universität München, 85748 Garching, Germany
- Gran Sasso Science Institute (INFN), 67100 Ł'Aquila, Italy
| | - S Appel
- Physik-Department and Excellence Cluster Universe, Technische Universität München, 85748 Garching, Germany
| | - G Bellini
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - J Benziger
- Chemical Engineering Department, Princeton University, Princeton, New Jersey 08544, USA
| | - D Bick
- Institut für Experimentalphysik, Universität Hamburg, 22761 Hamburg, Germany
| | - G Bonfini
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - D Bravo
- Physics Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - B Caccianiga
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - F Calaprice
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
- Gran Sasso Science Institute (INFN), 67100 Ł'Aquila, Italy
| | - A Caminata
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - P Cavalcante
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - A Chepurnov
- Lomonosov Moscow State University Skobeltsyn Institute of Nuclear Physics, 119234 Moscow, Russia
| | - D D'Angelo
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - S Davini
- Gran Sasso Science Institute (INFN), 67100 Ł'Aquila, Italy
| | - A Derbin
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - L Di Noto
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - I Drachnev
- Gran Sasso Science Institute (INFN), 67100 Ł'Aquila, Italy
| | - A Empl
- Department of Physics, University of Houston, Houston, Texas 77204, USA
| | - A Etenko
- NRC Kurchatov Institute, 123182 Moscow, Russia
| | - K Fomenko
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - D Franco
- AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, Sorbonne Paris Cité, 75205 Paris Cedex 13, France
| | - F Gabriele
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - C Galbiati
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - C Ghiano
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - M Giammarchi
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - M Goeger-Neff
- Physik-Department and Excellence Cluster Universe, Technische Universität München, 85748 Garching, Germany
| | - A Goretti
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - M Gromov
- Lomonosov Moscow State University Skobeltsyn Institute of Nuclear Physics, 119234 Moscow, Russia
- Lomonosov Moscow State University Faculty of Physics, 119234 Moscow, Russia
| | - C Hagner
- Institut für Experimentalphysik, Universität Hamburg, 22761 Hamburg, Germany
| | - E Hungerford
- Department of Physics, University of Houston, Houston, Texas 77204, USA
| | - Aldo Ianni
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
- Laboratorio Subterráneo de Canfranc, Paseo de los Ayerbe S/N, 22880 Canfranc, Estacion Huesca, Spain
| | - Andrea Ianni
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - K Jedrzejczak
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - M Kaiser
- Institut für Experimentalphysik, Universität Hamburg, 22761 Hamburg, Germany
| | - V Kobychev
- Kiev Institute for Nuclear Research, 03680 Kiev, Ukraine
| | - D Korablev
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - G Korga
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - D Kryn
- AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, Sorbonne Paris Cité, 75205 Paris Cedex 13, France
| | - M Laubenstein
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - B Lehnert
- Department of Physics, Technische Universität Dresden, 01062 Dresden, Germany
| | - E Litvinovich
- NRC Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - F Lombardi
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - P Lombardi
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - L Ludhova
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | | | - I Machulin
- NRC Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - S Manecki
- Physics Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - W Maneschg
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - S Marcocci
- Gran Sasso Science Institute (INFN), 67100 Ł'Aquila, Italy
| | - E Meroni
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - M Meyer
- Institut für Experimentalphysik, Universität Hamburg, 22761 Hamburg, Germany
| | - L Miramonti
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - M Misiaszek
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - M Montuschi
- Dipartimento di Fisica e Scienze della Terra Università degli Studi di Ferrara e INFN, 44122 Ferrara, Italy
| | - P Mosteiro
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - V Muratova
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - B Neumair
- Physik-Department and Excellence Cluster Universe, Technische Universität München, 85748 Garching, Germany
| | - L Oberauer
- Physik-Department and Excellence Cluster Universe, Technische Universität München, 85748 Garching, Germany
| | - M Obolensky
- AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, Sorbonne Paris Cité, 75205 Paris Cedex 13, France
| | - F Ortica
- Dipartimento di Chimica, Biologia e Biotecnologie, Università e INFN, 06123 Perugia, Italy
| | - K Otis
- Amherst Center for Fundamental Interactions and Physics Department, University of Massachusetts, Amherst, Massachusetts 01003, USA
| | - M Pallavicini
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - L Papp
- Physik-Department and Excellence Cluster Universe, Technische Universität München, 85748 Garching, Germany
| | - L Perasso
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - A Pocar
- Amherst Center for Fundamental Interactions and Physics Department, University of Massachusetts, Amherst, Massachusetts 01003, USA
| | - G Ranucci
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - A Razeto
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - A Re
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - A Romani
- Dipartimento di Chimica, Biologia e Biotecnologie, Università e INFN, 06123 Perugia, Italy
| | - R Roncin
- AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, Sorbonne Paris Cité, 75205 Paris Cedex 13, France
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - N Rossi
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - S Schönert
- Physik-Department and Excellence Cluster Universe, Technische Universität München, 85748 Garching, Germany
| | - D Semenov
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - H Simgen
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - M Skorokhvatov
- NRC Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - O Smirnov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - A Sotnikov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - S Sukhotin
- NRC Kurchatov Institute, 123182 Moscow, Russia
| | - Y Suvorov
- Physics and Astronomy Department, University of California Los Angeles (UCLA), Los Angeles, California 90095, USA
| | - R Tartaglia
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - G Testera
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - J Thurn
- Department of Physics, Technische Universität Dresden, 01062 Dresden, Germany
| | - M Toropova
- NRC Kurchatov Institute, 123182 Moscow, Russia
| | - E Unzhakov
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - A Vishneva
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - R B Vogelaar
- Physics Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - F von Feilitzsch
- Physik-Department and Excellence Cluster Universe, Technische Universität München, 85748 Garching, Germany
| | - H Wang
- Physics and Astronomy Department, University of California Los Angeles (UCLA), Los Angeles, California 90095, USA
| | - S Weinz
- Institute of Physics and Excellence Cluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - J Winter
- Institute of Physics and Excellence Cluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - M Wojcik
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - M Wurm
- Institute of Physics and Excellence Cluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - Z Yokley
- Physics Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - O Zaimidoroga
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - S Zavatarelli
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - K Zuber
- Department of Physics, Technische Universität Dresden, 01062 Dresden, Germany
| | - G Zuzel
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| |
Collapse
|
46
|
Otero S, Kaiser M, Pawlyn C, Giles S, Scurr E, Messiou C. Patient experience of whole body diffusion weighted magnetic resonance imaging (WB-MRI) for staging myeloma. Cancer Imaging 2015. [PMCID: PMC4601110 DOI: 10.1186/1470-7330-15-s1-p13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
47
|
Jones J, Cairns D, Sigsworth R, Collett C, Pawlyn C, Striha A, Melchor L, Kaiser M, Drayson M, Davies F, Gregory W, Boyd K, Owen R, Jackson G, Morgan G. Guidelines for the correct determination of second primary malignancies in myeloma trials. Clinical Lymphoma Myeloma and Leukemia 2015. [DOI: 10.1016/j.clml.2015.07.399] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
48
|
Agostini M, Appel S, Bellini G, Benziger J, Bick D, Bonfini G, Bravo D, Caccianiga B, Calaprice F, Caminata A, Cavalcante P, Chepurnov A, Choi K, D’Angelo D, Davini S, Derbin A, Di Noto L, Drachnev I, Empl A, Etenko A, Fiorentini G, Fomenko K, Franco D, Gabriele F, Galbiati C, Ghiano C, Giammarchi M, Goeger-Neff M, Goretti A, Gromov M, Hagner C, Houdy T, Hungerford E, Ianni A, Ianni A, Jedrzejczak K, Kaiser M, Kobychev V, Korablev D, Korga G, Kryn D, Laubenstein M, Lehnert B, Litvinovich E, Lombardi F, Lombardi P, Ludhova L, Lukyanchenko G, Machulin I, Manecki S, Maneschg W, Mantovani F, Marcocci S, Meroni E, Meyer M, Miramonti L, Misiaszek M, Montuschi M, Mosteiro P, Muratova V, Neumair B, Oberauer L, Obolensky M, Ortica F, Otis K, Pagani L, Pallavicini M, Papp L, Perasso L, Pocar A, Ranucci G, Razeto A, Re A, Ricci B, Romani A, Roncin R, Rossi N, Schönert S, Semenov D, Simgen H, Skorokhvatov M, Smirnov O, Sotnikov A, Sukhotin S, Suvorov Y, Tartaglia R, Testera G, Thurn J, Toropova M, Unzhakov E, Vogelaar R, von Feilitzsch F, Wang H, Weinz S, Winter J, Wojcik M, Wurm M, Yokley Z, Zaimidoroga O, Zavatarelli S, Zuber K, Zuzel G. Spectroscopy of geoneutrinos from 2056 days of Borexino data. Int J Clin Exp Med 2015. [DOI: 10.1103/physrevd.92.031101] [Citation(s) in RCA: 69] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
49
|
Kaiser M, Gough S, Woo V, Rodbard H, Linjawi S, Poulsen P, Korsholm L, Bode B. IDegLira bei Patienten mit Typ 2 Diabetes: Wirksamkeit und Sicherheit nach 1 Jahr. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
50
|
Kaiser M, Waehlert L, Rockel T, Kostev K. Einfluss der Einschreibung in einem Disease Management Programm auf die Einstellung von Diabetespatienten. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|